5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AMG 596, a novel anti-EGFRvIII bispecific T cell engager (BiTE®) molecule for the treatment of glioblastoma (GBM): Planned interim analysis in recurrent GBM (rGBM)
    Meeting Abstract

    Rosenthal, M. A.; Balana, C.; van Linde, M. E.; Sayehli, C.; Fiedler, W. M.; Wermke, M.; Massard, C.; Mellinghoff, I. K.; Khasraw, M.; Ang, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH-wildtype astrocytomas
    Meeting Abstract

    Lin, A.; Bale, T.; Mellinghoff, I.; Tabar, V.; Schaff, L.; Yang, T. J.; Young, R.; Taylor, B.; Rosenblum, M.; Jonsson, P.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Patient and physician perspectives on lumbar puncture
    Meeting Abstract

    Umemura, Y.; Weill, B.; Khan, B.; Buthorn, J.; Ridder, A.; Nevel, K.; Panageas, K.; Boire, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ib study of proton craniospinal irradiation for the treatment of solid tumor leptomeningeal metastases
    Meeting Abstract

    Yang, T. J.; Wolden, S.; Yamada, J.; Mehallow, M.; Skakodub, A.; Young, R.; Gavrilovic, I.; Lin, A.; Santomasso, B.; Grommes, C.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed or recurrent/refractory (R/R) glioblastoma (GBM): Phase 1b/2 study update
    Meeting Abstract

    Piotrowski, A.; Puduvalli, V.; Wen, P.; Campian, J.; Colman, H.; Pearlman, M.; Butowski, N.; Battiste, J.; Glass, J.; Cloughesy, T.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in Recurrent IDH1 mutant, low-grade glioma: Updated results
    Meeting Abstract

    Mellinghoff, I.; Cloughesy, T.; Wen, P.; Taylor, J.; Maher, E.; Arrillaga-Romany, I.; Peters, K.; Choi, C.; Ellingson, B.; Lin, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • "Primary" and "secondary" muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
    Correspondence

    Pietzak, E. J.; Al-Ahmadie, H.; Walasek, A.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B. H.; Solit, D. B.; Iyer, G.
    Translational Cancer Research (2019)

    Fulltext@MSK | Save
  • Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to predict and identify late recurrence, research directions
    Review

    Dowling, R. J. O.; Sparano, J. A.; Goodwin, P. J.; Bidard, F. C.; Cescon, D. W.; Chandarlapaty, S.; Deasy, J. O.; Dowsett, M.; Gray, R. J.; Henry, N. L.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Donor HLA-E status associates with disease-free survival and transplant-related mortality after non in vivo T cell-depleted HSCT for acute leukemia
    Journal Article

    Tsamadou, C.; Fürst, D.; Wang, T.; He, N.; Lee, S. J.; Spellman, S. R.; Fleischhauer, K.; Hsu, K. C.; Paczesny, S.; Verneris, M. R.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Are the long-term outcomes of percutaneous ablation for clinical stage T1 renal tumors similar to those of partial nephrectomy?
    Editorial

    Mano, R.; Hakimi, A. A.
    Annals of Translational Medicine (2019)

    Fulltext@MSK | Save